Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
The Argentine navy announced that a sound thought to be an explosion had been detected by US and specialist agencies leading the search.
Earlier this month the Kill Bill star said she was too angry to share her thoughts on the allegations swirling around Hollywood.
The former Manchester City forward has denied the allegation of gang rape and is expected to appeal.